€14.30
1.38% yesterday
Xetra, Feb 28, 05:36 pm CET
ISIN
DE000A0STSQ8
Symbol
M12

M1 Kliniken Target price 2025 - Analyst rating & recommendation

M1 Kliniken Classifications & Recommendation:

Buy
100%

M1 Kliniken Price Target

Target Price €27.50
Price €14.30
Potential
Number of Estimates 3
3 Analysts have issued a price target M1 Kliniken 2026 . The average M1 Kliniken target price is €27.50. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 3 Analysts recommend M1 Kliniken to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the M1 Kliniken stock has an average upside potential 2026 of . Most analysts recommend the M1 Kliniken stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Million € 316.32 340.78
10.88% 7.73%
EBITDA Margin 6.21% 8.89%
21.57% 43.18%
Net Margin 3.27% 4.43%
102.93% 35.65%

3 Analysts have issued a sales forecast M1 Kliniken 2024 . The average M1 Kliniken sales estimate is

€341m
Unlock
. This is
2.25% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€350m 4.90%
Unlock
, the lowest is
€330m 0.98%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 €316m 10.88%
2024
€341m 7.73%
Unlock
2025
€365m 7.18%
Unlock
2026
€396m 8.48%
Unlock

3 Analysts have issued an M1 Kliniken EBITDA forecast 2024. The average M1 Kliniken EBITDA estimate is

€30.3m
Unlock
. This is
8.10% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€32.0m 14.16%
Unlock
, the lowest is
€29.2m 4.17%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 €19.6m 34.80%
2024
€30.3m 54.28%
Unlock
2025
€35.0m 15.35%
Unlock
2026
€42.3m 20.98%
Unlock

EBITDA Margin

2023 6.21% 21.57%
2024
8.89% 43.18%
Unlock
2025
9.57% 7.65%
Unlock
2026
10.67% 11.49%
Unlock

1 Analyst has issued a net profit forecast M1 Kliniken 2024 . The average M1 Kliniken net profit estimate is

€15.1m
Unlock
. This is
10.24% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€15.1m 10.24%
Unlock
, the lowest is
€15.1m 10.24%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 €10.3m 125.00%
2024
€15.1m 46.27%
Unlock
2025
€19.9m 31.70%
Unlock
2026
€26.6m 33.62%
Unlock

Net Margin

2023 3.27% 102.93%
2024
4.43% 35.65%
Unlock
2025
5.45% 23.02%
Unlock
2026
6.71% 23.12%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share 0.54 0.79
125.00% 46.30%
P/E 18.35
EV/Sales 0.92

1 Analysts have issued a M1 Kliniken forecast for earnings per share. The average M1 Kliniken <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

€0.79
Unlock
. This is
10.23% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
€0.79 10.23%
Unlock
, the lowest is
€0.79 10.23%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 €0.54 125.00%
2024
€0.79 46.30%
Unlock
2025
€1.04 31.65%
Unlock
2026
€1.39 33.65%
Unlock

P/E ratio

Current 16.55 29.78%
2024
18.35 10.88%
Unlock
2025
13.94 24.03%
Unlock
2026
10.43 25.18%
Unlock

Based on analysts' sales estimates for 2024, the M1 Kliniken stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.95 15.85%
2024
0.92 2.65%
Unlock
2025
0.86 6.69%
Unlock
2026
0.80 7.82%
Unlock

P/S ratio

Current 0.83 12.35%
2024
0.81 2.20%
Unlock
2025
0.76 6.70%
Unlock
2026
0.70 7.81%
Unlock

Current M1 Kliniken Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
METZLER EQUITIES Locked ➜ Locked Locked Jan 06 2025
FIRST BERLIN EQUITY RESEARCH Locked ➜ Locked Locked Dec 19 2024
WARBURG RESEARCH GMBH Locked ➜ Locked Locked Nov 20 2024
Analyst Rating Date
Locked
METZLER EQUITIES: Locked ➜ Locked
Jan 06 2025
Locked
FIRST BERLIN EQUITY RESEARCH: Locked ➜ Locked
Dec 19 2024
Locked
WARBURG RESEARCH GMBH: Locked ➜ Locked
Nov 20 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today